<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35632649</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>27</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Epipharyngeal Abrasive Therapy (EAT) Has Potential as a Novel Method for Long COVID Treatment.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">907</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14050907</ELocationID><Abstract><AbstractText>COVID-19 often causes sequelae after initial recovery, referred to collectively as long COVID. Long COVID is considered to be caused by the persistence of chronic inflammation after acute COVID-19 infection. We found that all long COVID patients had residual inflammation in the epipharynx, an important site of coronavirus replication, and some long COVID symptoms are similar to those associated with chronic epipharyngitis. Epipharyngeal abrasive therapy (EAT) is a treatment for chronic epipharyngitis in Japan that involves applying zinc chloride as an anti-inflammatory agent to the epipharyngeal mucosa. In this study, we evaluated the efficacy of EAT for the treatment of long COVID. The subjects in this study were 58 patients with long COVID who were treated with EAT in the outpatient department once a week for one month (mean age = 38.4 &#xb1; 12.9 years). The intensities of fatigue, headache, and attention disorder, which are reported as frequent symptoms of long COVID, were assessed before and after EAT using the visual analog scale (VAS). EAT reduced inflammation in the epipharynx and significantly improved the intensity of fatigue, headache, and attention disorder, which may be related to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). These results suggest that EAT has potential as a novel method for long COVID treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Imai</LastName><ForeName>Kazuaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mirai Clinic, Fukuoka 812-0013, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamano</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka 814-0193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishi</LastName><ForeName>Soichiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nishi Otolaryngology Clinic, Fukuoka 814-0031, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishi</LastName><ForeName>Ryushiro</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Nishi Otolaryngology Clinic, Fukuoka 814-0031, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishi</LastName><ForeName>Tatsuro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nishi Otolaryngology Clinic, Fukuoka 814-0031, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Tanaka Hiroaki Clinic, Fukuoka 814-0142, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsunoda</LastName><ForeName>Toshiyuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshimoto</LastName><ForeName>Shohei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Pathology, Department of Morphological Biology, Division of Biomedical Sciences, Fukuoka Dental College, Fukuoka 814-0193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Ayaki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tanaka ENT Clinic, Osaka 553-0006, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiromatsu</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3496-6087</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirasawa</LastName><ForeName>Senji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakagawa</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishi</LastName><ForeName>Kensuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka 814-0193, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nishi Otolaryngology Clinic, Fukuoka 814-0031, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic epipharyngitis</Keyword><Keyword MajorTopicYN="N">epipharyngeal abrasive therapy (EAT)</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35632649</ArticleId><ArticleId IdType="pmc">PMC9147901</ArticleId><ArticleId IdType="doi">10.3390/v14050907</ArticleId><ArticleId IdType="pii">v14050907</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gorna R., MacDermott N., Rayner C., O&#x2019;Hara M., Evans S., Agyen L., Nutland W., Rogers N., Hastie C. Long COVID guidelines need to reflect lived experience. Lancet. 2021;397:455&#x2013;457. doi: 10.1016/S0140-6736(20)32705-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R., Gubbi S., Koch C.A. COVID-19 and chronic fatigue syndrome: An endocrine perspective. J. Clin. Transl. Endocrinol. 2022;27:100284. doi: 10.1016/j.jcte.2021.100284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigs J.K., Oqueka T., Harbaum L., Klose H. Organ-specific sequelae of COVID-19 in adults. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65:462&#x2013;470. doi: 10.1007/s00103-022-03513-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-022-03513-2</ArticleId><ArticleId IdType="pmc">PMC8925979</ArticleId><ArticleId IdType="pubmed">35294563</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Leber A., Jawad M.Y., Yu M., Lui L.M.W., Subramaniapillai M., Di Vincenzo J.D., Gill H., Rodrigues N.B., Cao B., et al. Registered clinical trials investigating treatment of long COVID: A scoping review and recommendations for research. Infect. Dis. 2022:2043560. doi: 10.1080/23744235.2022.2043560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2043560</ArticleId><ArticleId IdType="pmc">PMC8935463</ArticleId><ArticleId IdType="pubmed">35282780</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., Karachalias E., Suttels V., Haefliger D., Kampouri E., et al. Post-COVID-19 Syndrome in Outpatients: A Cohort Study. J. Gen. Intern. Med. 2022:1&#x2013;10. doi: 10.1007/s11606-021-07242-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07242-1</ArticleId><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi K., Yoshimoto S., Nishi S., Tsunoda T., Ohno J., Yoshimura M., Hiromatsu K., Yamano T. Epipharyngeal Abrasive Therapy Down-regulates the Expression of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2. In Vivo. 2022;36:371&#x2013;374. doi: 10.21873/invivo.12712.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.12712</ArticleId><ArticleId IdType="pmc">PMC8765169</ArticleId><ArticleId IdType="pubmed">34972736</ArticleId></ArticleIdList></Reference><Reference><Citation>Patarca R. Cytokines and chronic fatigue syndrome. Ann. N. Y. Acad. Sci. 2001;933:185&#x2013;200. doi: 10.1111/j.1749-6632.2001.tb05824.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2001.tb05824.x</ArticleId><ArticleId IdType="pubmed">12000020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotta O., Oda T. The epipharynx-kidney axis triggers glomerular vasculitis in immunoglobulin A nephropathy. Immunol. Res. 2019;67:304&#x2013;309. doi: 10.1007/s12026-019-09099-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-019-09099-3</ArticleId><ArticleId IdType="pubmed">31745821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotta O., Ieiri N., Inoue C., Tanaka A. Chronic epipharyngitis: A missing trigger in chronic fatigue syndrome. J. Transl. Sci. 2018;4:2&#x2013;3. doi: 10.15761/JTS.1000219.</Citation><ArticleIdList><ArticleId IdType="doi">10.15761/JTS.1000219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotta O., Ieiri N., Nagai M., Tanaka A., Harabuchi Y. Role of Palatine Tonsil and Epipharyngeal Lymphoid Tissue in the Development of Glomerular Active Lesions (Glomerular vasculitis) in Immunoglobulin A Nephropathy. Int. J. Mol. Sci. 2022;23:727. doi: 10.3390/ijms23020727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020727</ArticleId><ArticleId IdType="pmc">PMC8775943</ArticleId><ArticleId IdType="pubmed">35054911</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin I., Hotta O., Tani S. Epipharyngeal abrasive therapy in myalgic encephalomyelitis/chronic fatigue syndrome patients. Jpn. J. Clin. Med. 2021;79:989&#x2013;994.</Citation></Reference><Reference><Citation>Tanaka A. Specifics of each method of endoscopic transnasal epipharyngeal abrasive therapy (E-TN-EAT) and endoscopic transoral epipharyngeal abrasive therapy (E-TO-EAT) Stomato-Pharyngol. 2020;33:5&#x2013;16.</Citation></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogitate M., Sasaki Y., Komiyama A. Outcome of an outpatient specialty clinic for chronic epipharyngitis. Auris Nasus Larynx. 2021;48:451&#x2013;456. doi: 10.1016/j.anl.2020.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anl.2020.09.019</ArticleId><ArticleId IdType="pubmed">33067050</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A., Iqbal K., Arshad Ali S., Azim D., Farid E., Baig M.D., Bin Arif T., Raza M. The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors. Cureus. 2021;13:e13080. doi: 10.7759/cureus.13080.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13080</ArticleId><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994;121:953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins J.B., van der Meer J.W., Bleijenberg G. Chronic fatigue syndrome. Lancet. 2006;367:346&#x2013;355. doi: 10.1016/S0140-6736(06)68073-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68073-2</ArticleId><ArticleId IdType="pubmed">16443043</ArticleId></ArticleIdList></Reference><Reference><Citation>Naess H., Sundal E., Myhr K.M., Nyland H.I. Postinfectious and chronic fatigue syndromes: Clinical experience from a tertiary-referral centre in Norway. In Vivo. 2010;24:185&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">20363992</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M., Mastronardi C., Silva-Aldana C.T., Arcos-Burgos M., Lidbury B.A. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review. Diagnostics. 2019;9:91. doi: 10.3390/diagnostics9030091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030091</ArticleId><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Swiahb J.N., Motiwala M.A. Upper respiratory tract and otolaryngological manifestations of coronavirus disease 2019 (COVID-19): A systemic review. SAGE Open Med. 2021;9:1&#x2013;9. doi: 10.1177/20503121211016965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20503121211016965</ArticleId><ArticleId IdType="pmc">PMC8141987</ArticleId><ArticleId IdType="pubmed">34094558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L., Ramezani M., Darazam I.A., Sagharichi M., Aalipour M.A., Ghorbani F., Pakdaman H. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J. Neurovirology. 2021;27:154&#x2013;159. doi: 10.1007/s13365-021-00949-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00949-1</ArticleId><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H., Lu L., Fan H. Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis. Int. J. Environ. Res. Public Health. 2022;19:3742. doi: 10.3390/ijerph19063742.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19063742</ArticleId><ArticleId IdType="pmc">PMC8955790</ArticleId><ArticleId IdType="pubmed">35329428</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T., Gonevski M., Clark C., Baitule S., Sharma K., Magar A., Patel K., Sankar S., Kyrou I., Ali A., et al. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin. Med. 2021;21:e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Karosanidze I., Kiladze U., Kirtadze N., Giorgadze M., Amashukeli N., Parulava N., Iluridze N., Kikabidze N., Gudavadze N., Gelashvili L., et al. Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals. 2022;15:345. doi: 10.3390/ph15030345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15030345</ArticleId><ArticleId IdType="pmc">PMC8953947</ArticleId><ArticleId IdType="pubmed">35337143</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients. 2021;13:1154. doi: 10.3390/nu13041154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041154</ArticleId><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull D., Rennie P., Noronha A., Poore C., Harrington N., Fearnley V., Pass&#xe0;li D. Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold. Acta Otorhinolaryngol. Ital. 2007;27:73&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2640010</ArticleId><ArticleId IdType="pubmed">17608134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilding D.A. Literature review: The common cold. Ear Nose Throat J. 1994;73:639&#x2013;643. doi: 10.1177/014556139407300906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014556139407300906</ArticleId><ArticleId IdType="pubmed">7988393</ArticleId></ArticleIdList></Reference><Reference><Citation>Moneghetti K.J., Skhiri M., Contrepois K., Kobayashi Y., Maecker H., Davis M., Snyder M., Haddad F., Montoya J.G. Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Sci. Rep. 2018;8:2779. doi: 10.1038/s41598-018-20941-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20941-w</ArticleId><ArticleId IdType="pmc">PMC5807550</ArticleId><ArticleId IdType="pubmed">29426834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T., Yang Y., Wang D., Li C., Qu Y., Guo J., Shi T., Bo W., Sun Z., Asakawa T. The clinical value of cytokines in chronic fatigue syndrome. J. Transl. Med. 2019;17:213. doi: 10.1186/s12967-019-1948-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1948-6</ArticleId><ArticleId IdType="pmc">PMC6599310</ArticleId><ArticleId IdType="pubmed">31253154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M., Montoya J.G., Klimas N.G., Levine S., Felsenstein D., Bateman L., Peterson D.L., Gottschalk C.G., Schultz A.F., Che X., et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci. Adv. 2015;1:e1400121. doi: 10.1126/sciadv.1400121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1400121</ArticleId><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Twisk F.N., Johnson C. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: Results of supervised learning techniques applied on clinical and inflammatory data. Psychiatry Res. 2012;200:754&#x2013;760. doi: 10.1016/j.psychres.2012.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2012.03.031</ArticleId><ArticleId IdType="pubmed">22521895</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotta O., Inoue C., Tanaka A., Ieiri N. Possible Mechanisms Underlying Epipharyngeal Abrasive Therapy (EAT) with ZnCl2 Solution for the Treatment of Autoimmune Diseases and Functional Somatic Syndrome. J. Antivir. Antiretrovir. 2017;9:81&#x2013;86. doi: 10.4172/1948-5964.1000168.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/1948-5964.1000168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotta O., Tanaka A., Oda T. Chronic epipharyngitis: A missing background of IgA nephropathy. Autoimmun. Rev. 2019;18:835&#x2013;836. doi: 10.1016/j.autrev.2019.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.06.002</ArticleId><ArticleId IdType="pubmed">31176873</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi K., Nishi R., Kimura S., Nishi S., Tanaka H., Yamano T. Therapeutic effect of epipharyngeal abrasive therapy (EAT) on pharyngeal allergies. Stomato-Pharyngol. 2022;35:372&#x2013;374.</Citation></Reference><Reference><Citation>Maniaci A., Di Luca M., La Mantia I., Grillo C., Grillo C.M., Privitera E., Vicini C., Iannella G., Renna C., Bann&#xf2; V., et al. Surgical Treatment for the Refractory Allergic Rhinitis: State of the Art. Allergies. 2021;1:5. doi: 10.3390/allergies1010005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/allergies1010005</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise S.K., Lin S.Y., Toskala E., Orlandi R.R., Akdis C.A., Alt J.A., Azar A., Baroody F.M., Bachert C., Canonica G.W., et al. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. Int. Forum Allergy Rhinol. 2018;8:108&#x2013;352. doi: 10.1002/alr.22073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22073</ArticleId><ArticleId IdType="pmc">PMC7286723</ArticleId><ArticleId IdType="pubmed">29438602</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman F.A., Chavan S.S., Miljko S., Grazio S., Sokolovic S., Schuurman P.R., Mehta A.D., Levine Y.A., Faltys M., Zitnik R., et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 2016;113:8284&#x2013;8289. doi: 10.1073/pnas.1605635113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605635113</ArticleId><ArticleId IdType="pmc">PMC4961187</ArticleId><ArticleId IdType="pubmed">27382171</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Qi D., Li J.N., Deng X.Y., Wang D.X. Vagus nerve stimulation enhances the cholinergic anti-inflammatory pathway to reduce lung injury in acute respiratory distress syndrome via STAT3. Cell Death Discov. 2021;7:63. doi: 10.1038/s41420-021-00431-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00431-1</ArticleId><ArticleId IdType="pmc">PMC8005666</ArticleId><ArticleId IdType="pubmed">33782389</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats P., Giannakopoulos G., Blake J., Liebler E., Levy R.M. The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated with COVID-19: A Theoretical Hypothesis and Early Clinical Experience. Neuromodulation. 2020;23:784&#x2013;788. doi: 10.1111/ner.13172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ner.13172</ArticleId><ArticleId IdType="pmc">PMC7267613</ArticleId><ArticleId IdType="pubmed">32342609</ArticleId></ArticleIdList></Reference><Reference><Citation>Baptista A.F., Baltar A., Okano A.H., Moreira A., Campos A.C.P., Fernandes A.M., Brunoni A.R., Badran B.W., Tanaka C., de Andrade D.C., et al. Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19. Front. Neurol. 2020;11:573718. doi: 10.3389/fneur.2020.573718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573718</ArticleId><ArticleId IdType="pmc">PMC7724108</ArticleId><ArticleId IdType="pubmed">33324324</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan H., Silberstein S.D. Vagus Nerve Stimulation and Headache. Headache. 2017;57((Suppl. S1)):29&#x2013;33. doi: 10.1111/head.12721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.12721</ArticleId><ArticleId IdType="pubmed">26473407</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>